Is CBD Legal in Europe? The 2026 EU Laws & Country-by-Country CBD Guide

Is CBD legal in Europe in 2026? The answer depends on where you are. While the EU has made strides toward a unified approach, especially through novel food rules and the updated THC limits for hemp, each member state continues to enforce its own CBD regulations. This makes compliance tricky, but also opens up new opportunities for businesses able to navigate the patchwork of laws.

Let’s explore how the EU and its members are regulating CBD in 2026, starting with public attitudes, legal classification, and the rise of CBD as a wellness product.

All information verified as of January 2026.

The Shift Towards CBD Acceptance and Legal Challenges

CBD’s path to acceptance in Europe has been shaped by both scientific research and changing public opinion. While cannabis and its derivatives were once classified uniformly as narcotics, a greater understanding of cannabinoids, particularly cannabidiol (CBD), has shown that these compounds can offer therapeutic and wellness benefits without psychoactive effects.

This shift in perception led many countries to reclassify CBD, moving it out of narcotic frameworks and into the realm of wellness, food, and cosmetic products. However, legal acceptance has not been linear. CBD’s popularity sparked regulatory scrutiny, especially over product safety, sourcing, and the presence of THC, the intoxicating component of cannabis.

In the EU, the novel food regulation became a key legal hurdle. Because CBD was not widely consumed before May 15, 1997, it is considered “novel” and must undergo safety evaluations before approval for sale in food supplements. The result? A regulatory bottleneck that created confusion among producers, retailers, and consumers alike.

At the same time, countries have responded differently to this uncertainty. While some allowed CBD products under specific conditions, others banned oral or flower-based CBD entirely. The CBD market across Europe remains vibrant—but fragmented.

How do the specific regulations impact my CBD business?

f you're planning to start or expand a CBD business in Europe, understanding local laws isn’t optional, but essential. Even though CBD is widely accepted as a wellness product, the legal definition of what qualifies as a compliant product varies significantly between EU countries. This means that your business strategy must be shaped by both EU-level guidelines and national enforcement practices.

In most cases, CBD is classified either as a cosmetic, food supplement, or pharmaceutical, depending on the product type and its intended use. Each category has different legal and regulatory implications:

• Cosmetics: Allowed in most EU countries if the CBD is derived from hemp, THC-free, and listed in the CosIng database.
• Food Supplements: Must go through the novel food application process with the European Food Safety Authority (EFSA) before entering the market. Some countries enforce this strictly, while others tolerate products awaiting approval.
• Medicinal CBD: Requires formal marketing authorization, available only to licensed pharmaceutical companies.

Whether you're launching a white-label CBD oil, producing full-spectrum extracts, or selling CBD-infused cosmetics, you need to navigate each country’s specific compliance rules. For example, some jurisdictions only permit THC-free CBD isolate, while others accept full-spectrum extracts with up to 0.3% THC or higher under local exceptions.

International sales introduce even more complexity. You’ll need to comply with both export rules in your country and import regulations in the destination country. Missteps here can lead to seized shipments, regulatory fines, or bans.

The good news? The EU’s regulatory trend is leaning toward harmonization and simplification of processes, which means the long-term outlook for cross-border CBD business is positive, especially for companies that invest early in compliance and quality assurance.

Is CBD completely legal in the entire European Union?

The short answer is: no. CBD is not completely legal in the same way across all EU countries. While the European Union sets certain regulatory baselines, such as the THC limit of 0.3% for hemp and the classification of CBD as a novel food or cosmetic, the actual enforcement of these rules is up to individual member states.

Some countries, like Germany, the Czech Republic, and the Netherlands, have developed frameworks that support a wide range of CBD products, from full-spectrum oils to CBD edibles and cosmetics. Others, like Sweden or Italy, enforce stricter limitations, often restricting sales to THC-free isolate or banning CBD in certain product forms like flowers or oral tinctures.

This fragmented legal landscape means that CBD may be:

• Freely sold as a cosmetic or supplement in one country,
• Banned from oral consumption in another,
• Or only available via prescription under pharmaceutical law.

This patchwork of regulations creates confusion for both consumers and companies—particularly those engaged in cross-border e-commerce or white-label CBD manufacturing. In practice, the legality of your product may come down to details such as THC content, extraction method, and whether the product is labeled as a food, supplement, or cosmetic.

Still, there is reason for optimism. As of 2026, more countries are aligning their national policies with EU recommendations and CJEU rulings. The gradual implementation of EFSA-approved novel food applications and recognition of non-narcotic CBD provide a pathway toward clearer, unified standards.

Until then, any business operating in the CBD space should conduct a country-by-country legal review before launching or distributing products.

2021–2025 Updates: Key Milestones in EU CBD Regulation

2021: CosIng Opens the Door to CBD in Cosmetics

In February 2021, the European Commission officially listed Cannabidiol (CBD) in the CosIng database, allowing naturally derived CBD to be used in cosmetics across the EU. This was a turning point for the CBD skincare and wellness sector, as it clarified that non-synthetic CBD, when THC-free and properly sourced, could be safely incorporated into topical products.

2022: EFSA Puts Novel Food Approvals on Hold

By mid-2022, 19 applications had been submitted to the European Food Safety Authority (EFSA) for CBD products to be classified as novel food. However, EFSA paused all evaluations, citing the need for more safety data on CBD’s long-term effects on humans. This created uncertainty, but not a rejection; EFSA clarified that the pause was procedural, not based on safety concerns.

2023: New EU CAP Raises THC Limit for Hemp

With the 2023 Common Agricultural Policy (CAP) reform, the allowable THC threshold in hemp cultivation rose from 0.2% to 0.3%, aligning with international norms and encouraging EU hemp farming. The new CAP also offered subsidies for eco-friendly hemp farming, provided THC levels remained under the threshold. However, individual countries still retain the right to set lower national limits.

2024–2025: Momentum Builds Toward Harmonization

In late 2024 and early 2025, the EFSA resumed the evaluation of novel food applications and began granting the first approvals for CBD supplements. This has given manufacturers clearer guidance and the ability to plan future product development in line with EU standards.

Meanwhile, some countries, such as Italy, France, and Germany, have updated national laws to reflect the EU THC threshold and allow for broader product ranges, including full-spectrum oils, edibles, and beverages. However, others still impose stricter rules or bans, particularly on CBD flower.

Lastly, sustainability has become a key focus. Under the CAP, more hemp farmers now qualify for EU subsidies if their practices are eco-certified, promoting local sourcing and reducing reliance on CBD imports.

2026: EU-wide Novel Food Status

As of January 2026, ingestible CBD products in the European Union remain subject to the Novel Food framework. The European Food Safety Authority (EFSA) placed CBD novel food assessments on hold after identifying significant data gaps related to safety, particularly regarding long-term consumption and effects on the liver and nervous system.

While regulatory discussions and scientific evaluations are ongoing, EU-level authorisation for orally consumed CBD has not yet been fully resolved. As a result, enforcement continues to vary by member state, and businesses should treat ingestible CBD products as a high-compliance, country-specific category rather than relying on EU-wide approval.

Country-by-country Guide

Austria - YES, with a prescription

CBD is available in Austria, but ingestible CBD remains legally sensitive due to Novel Food rules. In practice, many CBD oils are sold using “non-ingestible” positioning (for example “aroma” or “technical use”), while cosmetics are more straightforward.

• Hemp Cultivation: Legal under authorization using approved hemp varieties. Austria aligns with EU cultivation rules (eligible varieties ≤ 0.3% THC at cultivation level).
• CBD Flowers: Often treated as a high-risk category. Retail availability exists in practice, but legal certainty is limited and enforcement can vary.
• CBD Products: CBD in food and food supplements is generally treated as Novel Food. As of January 2026, CBD extracts have not received broad EU authorisation for food use, so ingestible positioning remains risky. Cosmetics and topicals are more accessible if compliant.
• Medical Cannabis: Allowed only in limited forms (approved medicines / regulated access).
• Recreational Cannabis: Illegal.
• Consumer Access: Moderate for cosmetics; mixed for oils depending on labeling and intended use; higher risk for ingestible supplements and flowers.

Austria is commercially active, but the safest positioning is cosmetic/topical, while food supplement claims should be avoided without a strong compliance strategy.

 

Belgium - Yes, with a prescription

CBD remains in a legal gray area in Belgium. While not classified as a narcotic, its sale and marketing are subject to strict regulations.

• Hemp Cultivation: Legal for industrial purposes with permits. Personal cultivation not allowed.
• CBD Flowers: Freely sold and consumed despite unclear legal status. Enforcement is minimal.
• CBD Products: Cosmetics are legal. Oils and edibles are technically not approved but sold under "not for consumption" labels.
• Medical Cannabis: Permitted for specific conditions; limited prescription-based availability.
• Recreational Cannabis: Decriminalized in small amounts for adults. Cultivation and sale remain illegal.
• Consumer Access: Products widely accessible in shops and online under tolerated frameworks.

Businesses must ensure compliance with labeling and marketing regulations to avoid legal issues. As EU regulations evolve, Belgium may adjust its stance, potentially creating more opportunities for CBD entrepreneurs and consumers.

 

Bulgaria - Yes

CBD is widely available in Bulgaria, but its legal treatment depends on product category and EU-level rules. While Bulgaria has historically been one of the more permissive EU markets for CBD retail, ingestible CBD products still intersect with the EU Novel Food framework, and national practice does not formally override EU food law classification.

• Hemp Cultivation: Legal with a license. Industrial hemp cultivation follows EU rules for eligible varieties, including the EU cultivation THC threshold (0.3%). Hemp may be used for fiber, food, and cannabinoid extraction.
• CBD Flowers: Available in some shops and online. Regulation is relatively light compared to many EU countries, though enforcement practices may vary.
• CBD Products: CBD oils, supplements, and cosmetics are widely sold in practice. However, ingestible CBD products are not formally exempt from EU Novel Food requirements, despite market availability.
• Medical Cannabis: Not permitted. There is no legal framework for medical cannabis prescriptions or distribution.
• Recreational Cannabis: Illegal. Possession and use remain criminal offenses.
• Consumer Access: Broad access in practice without prescription, particularly for non-ingestible products. Businesses should nevertheless assess Novel Food exposure when placing edible or supplement CBD products on the market.

Bulgaria remains one of the more commercially accessible CBD markets in the EU, but companies should distinguish between retail availability and formal regulatory status, especially for ingestible products.

 

Croatia - Yes

CBD is legal in Croatia when derived from industrial hemp containing less than 0.2% THC. The country permits the sale and use of CBD products that meet this criterion.

• Hemp Cultivation: Legal with government approval. THC content must remain below 0.2%.
• CBD Flowers: Available in shops but not specifically regulated. Tolerated when under THC limit.
• CBD Products: Oils, supplements, and cosmetics are widely sold both domestically and online.
• Medical Cannabis: Legal with prescription since 2015. Available for select conditions.
• Recreational Cannabis: Decriminalized for personal use. Possession punished with fines.
• Consumer Access: Easy access to a wide range of products within EU THC limits.

Croatia's clear regulatory framework supports a growing CBD market, offering opportunities for businesses and consumers alike, as long as they adhere to the established guidelines.

 

Cyprus - Yes (with restrictions)

CBD is legal in Cyprus if it is derived from industrial hemp and contains less than 0.2% THC at every stage of production. However, the legal environment remains complicated, with occasional enforcement actions creating uncertainty for both businesses and consumers.

• Hemp Cultivation: Permitted with a license for industrial purposes. THC content must remain below 0.2%.
• CBD Flowers: Not clearly regulated; sales exist but are legally ambiguous and may be subject to enforcement.
• CBD Products: Oils, cosmetics, and supplements are available in physical and online shops. Products must meet safety and labeling standards.
• Medical Cannabis: Legal for approved conditions. Access has expanded since 2019 to include patients beyond cancer cases.
• Recreational Cannabis: Illegal. Possession and use are criminal offenses and may lead to fines or imprisonment.
• Consumer Access: Widely available without a prescription, though crackdowns on certain product types (e.g., edibles) have occurred.

The Cypriot CBD market operates within EU norms but requires careful navigation due to evolving enforcement patterns and product-specific scrutiny.

 

Czech Republic/Czechia - Yes

CBD is legal in Czechia, and the country introduced a new regulated model for certain low-risk psychoactive products starting 1 July 2025, including low-THC cannabis products under controlled retail rules.

• Hemp Cultivation: Legal for approved industrial hemp varieties (EU cultivation threshold ≤ 0.3% THC for eligible varieties).
• CBD Flowers: More tolerated than in many EU markets, but rules depend on THC content, product type, and the specific regulated category.
• CBD Products: CBD products are widely available. Ingestible CBD still intersects with Novel Food constraints, but Czechia’s regulatory approach is among the more structured. Under the 2025 framework, low-THC products up to 1% THC can be allowed through licensed, regulated sales channels for adults.
• Medical Cannabis: Legal under a regulated medical framework.
• Recreational Cannabis: Not fully legal as a general market, but Czechia is moving toward broader reform and has created a regulated pathway for low-THC “psychomodulatory” products (from July 2025).
• Consumer Access: High relative to many EU countries, especially through regulated channels.

Czechia is one of the most progressive markets in Europe, but businesses should still separate CBD from the newer ≤1% THC regulated category and stay compliant on labeling and distribution.

Denmark - Yes (with restrictions)

CBD is legal in Denmark when derived from industrial hemp containing less than 0.2% THC. However, the regulatory environment is nuanced, with distinctions between food supplements and medicinal products.

• Hemp Cultivation: Permitted under license for industrial purposes. Farmers must comply with THC content regulations.
• CBD Flowers: Legally ambiguous. While not explicitly banned, their sale is not clearly regulated, leading to a gray market.
• CBD Products: Oils, cosmetics, and supplements are available in stores and online. Products must meet quality and labeling standards, and those making medicinal claims may require authorization as medicines.
• Medical Cannabis: Legal under the Medicinal Cannabis Pilot Programme, which has been made permanent effective January 1, 2026. Doctors can prescribe cannabis-based medicines for specific conditions.
• Recreational Cannabis: Illegal. Possession and use of cannabis are criminal offenses, with penalties including fines and imprisonment.
• Consumer Access: CBD products are accessible without a prescription, provided they comply with the legal THC limit and labeling requirements.

Denmark's regulatory framework supports a growing CBD market, but businesses and consumers must navigate the complex legal landscape carefully.

 

Estonia - Yes (with restrictions)

CBD is legal in Estonia when derived from industrial hemp containing less than 0.3% THC. However, the regulatory environment imposes specific restrictions on the sale and marketing of CBD products.

• Hemp Cultivation: Permitted for industrial purposes under EU regulations. Farmers must ensure THC content remains below 0.3%.
• CBD Flowers: Legally ambiguous. While not explicitly banned, their sale is not clearly regulated, leading to a gray market.
• CBD Products: CBD oils, capsules, and other ingestible products are considered unauthorized novel foods and cannot be marketed for internal consumption. Cosmetic products containing CBD are allowed, provided they do not contain hemp flowers or extracts derived from them.
• Medical Cannabis: Legal under strict regulation. Access requires a special permit, and products are available through authorized channels.
• Recreational Cannabis: Decriminalized for possession of up to 7.5 grams, punishable by a fine. Possession of larger amounts or intent to distribute remains illegal.
• Consumer Access: CBD products are available, but consumers should be aware of the restrictions on ingestible forms and ensure products comply with local regulations.

Estonia's regulatory framework allows for the presence of CBD products in the market, but businesses and consumers must navigate the specific restrictions, particularly concerning ingestible products and marketing claims.

 

Finland - Yes, with a doctor's prescription

CBD is classified as a prescription-only medicine in Finland, regulated by the Finnish Medicines Agency (Fimea). This means that any CBD-containing product intended for human consumption requires a doctor's prescription. Over-the-counter sales of CBD products are not permitted.

• Hemp Cultivation: Permitted for industrial purposes under EU regulations. Farmers must ensure THC content remains below 0.2%.
• CBD Flowers: Not legally available. The sale and possession of CBD-rich hemp flowers are prohibited, regardless of THC content.
• CBD Products: All CBD products intended for human consumption are considered medicines and require a prescription. Importing such products without proper authorization is illegal. Cosmetic products containing CBD may be allowed if they meet specific regulatory requirements.
• Medical Cannabis: Legal under strict regulation. Access requires a special permit, and products are available through authorized channels.
• Recreational Cannabis: Illegal. Possession and use of cannabis are criminal offenses, with penalties including fines and imprisonment.
• Consumer Access: CBD products are only accessible with a doctor's prescription. Importing CBD products for personal use is subject to strict regulations and may be prohibited without proper authorization.

Finland's regulatory framework classifies CBD as a medicinal product, necessitating a prescription for legal access. Consumers and businesses must navigate these stringent regulations to ensure compliance.

 

France - Yes (with restrictions)

CBD is legal in France when derived from authorized industrial hemp varieties and containing no more than 0.3% THC. However, French rules remain strict in practice, especially around product positioning, claims, and finished-product compliance. Ingestible CBD also continues to face EU Novel Food-related constraints.

• Hemp Cultivation: Legal under authorization using approved hemp varieties. Cultivation follows the EU cultivation threshold of ≤ 0.3% THC for eligible varieties.
• CBD Flowers: Legal only under strict conditions (approved hemp varieties and ≤ 0.3% THC). Retail availability exists, but enforcement can be inconsistent depending on region and product presentation.
• CBD Products: CBD cosmetics and non-ingestible products are widely available. Ingestible CBD (oils/supplements/edibles) remains constrained by Novel Food status and local enforcement. Avoid positioning ingestible CBD as a “food supplement” without a robust compliance strategy.
• Medical Cannabis: Legal within a regulated medical framework (scope and access depend on national program conditions and approvals).
• Recreational Cannabis: Illegal. Possession and use remain prohibited.
• Consumer Access: Moderate to high for cosmetics and non-ingestible CBD; more restricted and legally sensitive for ingestible products due to Novel Food exposure.

France is commercially active for CBD, but businesses should separate flower legality (≤0.3% THC, approved varieties) from ingestible legality (Novel Food constraints + enforcement risk).

 

Germany - Yes

CBD is widely sold in Germany, but legality depends heavily on product category. Germany adopted major cannabis reforms in 2024, but this did not automatically legalize CBD foods. Ingestible CBD products still face Novel Food constraints and enforcement.

• Hemp Cultivation: Legal under license for approved industrial hemp varieties. Germany aligns with the EU cultivation threshold of ≤ 0.3% THC for eligible varieties (historically 0.2%).
• CBD Flowers: High legal risk. Even when derived from low-THC hemp, consumer sale/possession is often treated as non-permitted due to “abuse for intoxication cannot be excluded” logic. Enforcement varies, but flowers are commonly treated as a problem category.
• CBD Products: Cosmetics and topical products are broadly available. CBD oils and supplements intended for ingestion are frequently treated as non-marketable food/food supplements due to Novel Food classification. Product legality is typically assessed case-by-case (claims, labeling, intended use, THC traces).
• Medical Cannabis: Legal in a regulated medical framework. Medical access exists through prescription pathways.
• Recreational Cannabis: Partially legalized (2024 reform) under specific conditions, but this does not create automatic legality for CBD foods.
• Consumer Access: High for cosmetics; mixed for CBD oils depending on labeling/claims; low certainty for ingestible supplements/edibles; high risk for flowers.

Germany is a large CBD market, but companies should treat flowers and ingestibles as the two most sensitive categories.

 

Greece - Yes

CBD products are legal in Greece, provided they are derived from industrial hemp and contain less than 0.2% THC.

• Hemp Cultivation: Permitted for industrial purposes under strict licensing. Farmers must use EU-certified seeds and ensure THC content remains below 0.2%.
• CBD Flowers: Available for sale if the THC content is under 0.2%.
• CBD Products: CBD oils, cosmetics, and topicals are legal and widely available. Ingestible CBD products, such as food supplements, fall under the EU Novel Food Regulation and require authorization before being marketed.
• Medical Cannabis: Legal since 2017. Patients with qualifying conditions can access medical cannabis products through licensed pharmacies with a doctor's prescription.
• Recreational Cannabis: Illegal. Possession and use are criminal offenses, though possession of small amounts may result in a fine.
• Consumer Access: CBD products meeting legal requirements are widely available in pharmacies, health stores, and online. Consumers should ensure products comply with THC limits and are sourced from authorized hemp varieties.

Greece's regulatory framework allows for the sale and use of CBD products under specific conditions, aligning with EU standards.

 

Hungary - Yes (with restrictions)

In Hungary, CBD products are legal under specific conditions, primarily concerning their THC content and intended use.

• Hemp Cultivation: Permitted for industrial purposes using EU-certified seeds, provided the THC content does not exceed 0.2%.
• CBD Flowers: The sale and possession of CBD-rich hemp flowers are prohibited, regardless of THC content.
• CBD Products: CBD oils and cosmetics are legal if they contain less than 0.2% THC and are derived from authorized hemp varieties. However, ingestible CBD products, such as supplements and edibles, require authorization under the EU Novel Food Regulation and are not yet approved for the market.
• Medical Cannabis: Legal in theory, but access is highly restricted. Only specific cannabis-based medications, like Sativex, are authorized, and prescriptions are rarely issued.
• Recreational Cannabis: Illegal. Hungarian law does not differentiate between types of illicit drugs, and possession of cannabis can lead to severe penalties, including imprisonment.
• Consumer Access: CBD products meeting legal requirements are available in stores and online. Consumers should ensure products comply with THC limits and are sourced from authorized hemp varieties.

Hungary's regulatory framework for CBD is stringent, with clear distinctions between permissible products and those requiring further authorization.

 

Ireland - Yes (with restrictions)

In Ireland, CBD products are legal under stringent conditions, primarily concerning their THC content and intended use.

• Hemp Cultivation: Permitted under license from the Department of Health. Cultivation is restricted to EU-certified hemp varieties with THC content below 0.3%. However, the processing or sale of hemp flowers and leaves is prohibited; these parts must be destroyed upon harvest.
• CBD Flowers: The sale and possession of CBD-rich hemp flowers are prohibited, regardless of THC content.
• CBD Products: CBD oils and cosmetics are legal if they contain no detectable THC and are derived from authorized hemp varieties. Ingestible CBD products, such as supplements and edibles, require authorization under the EU Novel Food Regulation and are not yet approved for the market.
• Medical Cannabis: Legal under the Medical Cannabis Access Programme (MCAP) for specific conditions like multiple sclerosis, chemotherapy-induced nausea, and treatment-resistant epilepsy. Access requires a prescription from a specialist consultant.
• Recreational Cannabis: Illegal. Possession and use are criminal offenses, with penalties including fines and imprisonment.
• Consumer Access: CBD products meeting legal requirements are available in stores and online. Consumers should ensure products contain no detectable THC and are sourced from authorized hemp varieties.

Ireland's regulatory framework for CBD is stringent, with clear distinctions between permissible products and those requiring further authorization.

 

Italy - No (except by prescription)

CBD in Italy is subject to significant legal uncertainty, particularly for ingestible products. While industrial hemp is permitted under EU and national law, oral CBD products have faced increased regulatory scrutiny and enforcement since 2024–2025, with authorities treating CBD extracts as narcotic substances in several cases.

• Hemp Cultivation: Legal with authorization. Italy follows EU hemp cultivation rules, allowing approved industrial hemp varieties containing up to 0.3% THC at cultivation level. National tolerance rules have historically allowed up to 0.6% THC in crops, but this does not apply to finished products.
• CBD Flowers: Highly restricted. CBD flowers are commonly treated as cannabis material regardless of THC content, and retail sale faces frequent enforcement action.
• CBD Products: Ingestible CBD products (oils, supplements, edibles) are effectively restricted. Authorities have increasingly classified CBD extracts as narcotic substances, regardless of THC content, leading to withdrawals and seizures. No clear national THC threshold is applied to finished CBD products.
• Medical Cannabis: Legal under a regulated framework. Cannabis-based medicines may be prescribed for specific conditions and dispensed through pharmacies.
• Recreational Cannabis: Illegal. Possession remains a criminal offense, subject to administrative or penal sanctions depending on quantity.
• Consumer Access: Very limited for CBD, especially oral products. Market availability exists in practice, but legal certainty is low and enforcement risk is high.

Italy currently represents one of the highest-risk CBD markets in the EU, particularly for ingestible products, due to restrictive interpretation and ongoing legal disputes.

 

Latvia - Yes

CBD products are legal in Latvia, provided they are derived from industrial hemp and contain less than 0.2% THC.

• Hemp Cultivation: Permitted for industrial purposes using EU-certified seeds, with THC content not exceeding 0.2%.
• CBD Flowers: The sale and possession of CBD-rich hemp flowers are prohibited, regardless of THC content.
• CBD Products: CBD oils and cosmetics are legal if they contain less than 0.2% THC and are derived from authorized hemp varieties. Ingestible CBD products, such as supplements and edibles, require authorization under the EU Novel Food Regulation.
• Medical Cannabis: Legal under strict conditions. Access to cannabis-based medications requires a prescription and is limited to specific medical conditions.
• Recreational Cannabis: Illegal. Possession and use are criminal offenses, with penalties including fines and imprisonment.
• Consumer Access: CBD products meeting legal requirements are available in stores and online. Consumers should ensure products comply with THC limits and are sourced from authorized hemp varieties.

Latvia's regulatory framework for CBD aligns with EU standards, allowing for the sale and use of compliant products.

 

Lithuania - Yes

CBD products are legal in Lithuania, provided they are derived from industrial hemp and contain less than 0.2% THC.

• Hemp Cultivation: Permitted for industrial purposes using EU-certified seeds, with THC content not exceeding 0.2%.
• CBD Flowers: The sale and possession of CBD-rich hemp flowers are prohibited, regardless of THC content.
• CBD Products: CBD oils and cosmetics are legal if they contain less than 0.2% THC and are derived from authorized hemp varieties. Ingestible CBD products, such as supplements and edibles, require authorization under the EU Novel Food Regulation.
• Medical Cannabis: Legal under strict conditions. Access to cannabis-based medications requires a prescription and is limited to specific medical conditions.
• Recreational Cannabis: Illegal. Possession and use are criminal offenses, with penalties including fines and imprisonment.
• Consumer Access: CBD products meeting legal requirements are available in stores and online. Consumers should ensure products comply with THC limits and are sourced from authorized hemp varieties.

Lithuania's regulatory framework for CBD aligns with EU standards, allowing for the sale and use of compliant products.

 

Luxembourg - Yes

CBD products are legal in Luxembourg, provided they are derived from industrial hemp and contain less than 0.3% THC.

• Hemp Cultivation: Permitted for industrial purposes using EU-certified seeds, with THC content not exceeding 0.3%.
• CBD Flowers: The sale and possession of CBD-rich hemp flowers are prohibited, regardless of THC content.
• CBD Products: CBD oils and cosmetics are legal if they contain less than 0.3% THC and are derived from authorized hemp varieties. Ingestible CBD products, such as supplements and edibles, require authorization under the EU Novel Food Regulation.
• Medical Cannabis: Legal under strict conditions. Access to cannabis-based medications requires a prescription and is limited to specific medical conditions.
• Recreational Cannabis: Decriminalized. Possession of small amounts for personal use is subject to fines but not criminal prosecution.
• Consumer Access: CBD products meeting legal requirements are available in stores and online. Consumers should ensure products comply with THC limits and are sourced from authorized hemp varieties.

Luxembourg's regulatory framework for CBD aligns with EU standards, allowing for the sale and use of compliant products.

 

Malta - Yes, with a prescription

In Malta, CBD products are legal under specific conditions, primarily concerning their THC content and intended use.

• Hemp Cultivation: Permitted for industrial purposes using EU-certified seeds, with THC content not exceeding 0.2%.
• CBD Flowers: The sale and possession of CBD-rich hemp flowers are prohibited, regardless of THC content.
• CBD Products: CBD oils and cosmetics are legal if they contain less than 0.2% THC and are derived from authorized hemp varieties. Ingestible CBD products, such as supplements and edibles, require authorization under the EU Novel Food Regulation.
• Medical Cannabis: Legal under strict conditions. Access to cannabis-based medications requires a prescription and is limited to specific medical conditions.
• Recreational Cannabis: Decriminalized. Possession of small amounts for personal use is subject to fines but not criminal prosecution.
• Consumer Access: CBD products meeting legal requirements are available in stores and online. Consumers should ensure products comply with THC limits and are sourced from authorized hemp varieties.

Malta's regulatory framework for CBD aligns with EU standards, allowing for the sale and use of compliant products.

 

The Netherlands - Yes (with nuances)

CBD is permitted in the Netherlands, but it has one of Europe’s strictest finished-product THC tolerances. In practice, CBD products are expected to contain no more than 0.05% THC.

• Hemp Cultivation: Legal for approved hemp varieties under EU rules (cultivation threshold ≤ 0.3% THC for eligible varieties).
• CBD Flowers: Grey area. Flowers are closely associated with cannabis and can create enforcement risk, even when THC is low.
• CBD Products: CBD oils and related products are generally only tolerated if they comply with Dutch rules, including a finished-product THC ceiling of ≤ 0.05% THC and strict restrictions on medical claims. Ingestible CBD still intersects with Novel Food risk.
• Medical Cannabis: Legal under a regulated program.
• Recreational Cannabis: Tolerated in the well-known “gedoogbeleid” system (tolerance policy) but remains legally complex.
• Consumer Access: Moderate, but heavily dependent on THC trace compliance (≤0.05% THC) and non-medical marketing.

For market entry, the Netherlands is mainly a THC-trace compliance challenge. Products acceptable elsewhere in the EU may fail Dutch thresholds.

Poland - Yes

CBD products are legal in Poland, provided they are derived from industrial hemp and contain less than 0.3% THC.

• Hemp Cultivation: Permitted for industrial purposes using EU-certified seeds, with THC content not exceeding 0.3%.
• CBD Flowers: The sale and possession of CBD-rich hemp flowers are prohibited, regardless of THC content.
• CBD Products: CBD oils and cosmetics are legal if they contain less than 0.3% THC and are derived from authorized hemp varieties. Ingestible CBD products, such as supplements and edibles, require authorization under the EU Novel Food Regulation.
• Medical Cannabis: Legal under strict conditions. Access to cannabis-based medications requires a prescription and is limited to specific medical conditions.
• Recreational Cannabis: Illegal. Possession and use are criminal offenses, with penalties including fines and imprisonment.
• Consumer Access: CBD products meeting legal requirements are available in stores and online. Consumers should ensure products comply with THC limits and are sourced from authorized hemp varieties.

Poland's regulatory framework for CBD aligns with EU standards, allowing for the sale and use of compliant products.

 

Portugal - Yes, with a prescription

CBD legality in Portugal depends strongly on product category and regulatory interpretation, with strict enforcement observed since 2024. While medical cannabis is legal, CBD products face significant regulatory scrutiny.

• Hemp Cultivation: Legal under license. Industrial hemp cultivation follows EU rules, allowing approved varieties with up to 0.3% THC at the cultivation level.
• CBD Flowers: Generally restricted. CBD flowers are not widely accepted for retail sale, regardless of THC content.
• CBD Products: Ingestible CBD products continue to face EU Novel Food restrictions and are not clearly authorised as food supplements. In 2024–2025, the Portuguese regulator Infarmed ordered the withdrawal of multiple CBD cosmetic products, particularly where CBD was derived from cannabis extracts rather than approved plant parts. No formal THC threshold guarantees legality for finished CBD products.
• Medical Cannabis: Legal under a licensed framework. Cannabis-based medicines are available by prescription through authorised pharmacies.
• Recreational Cannabis: Illegal. Possession remains unlawful, though enforcement focuses primarily on trafficking rather than personal use.
• Consumer Access: Limited. CBD availability is constrained by strict regulatory interpretation, affecting both ingestible products and cosmetics.

Portugal should be considered a high-compliance and high-risk market for CBD businesses, even where THC levels are minimal.

 

Romania - Yes

CBD products are legal in Romania, provided they are derived from industrial hemp and contain less than 0.2% THC.

• Hemp Cultivation: Permitted for industrial purposes using EU-certified seeds, with THC content not exceeding 0.2%.
• CBD Flowers: The sale and possession of CBD-rich hemp flowers are prohibited, regardless of THC content.
• CBD Products: CBD oils and cosmetics are legal if they contain less than 0.2% THC and are derived from authorized hemp varieties. Ingestible CBD products, such as supplements and edibles, require authorization under the EU Novel Food Regulation.
• Medical Cannabis: Legal under strict conditions. Access to cannabis-based medications requires a prescription and is limited to specific medical conditions.
• Recreational Cannabis: Illegal. Possession and use are criminal offenses, with penalties including fines and imprisonment.
• Consumer Access: CBD products meeting legal requirements are available in stores and online. Consumers should ensure products comply with THC limits and are sourced from authorized hemp varieties.

Romania's regulatory framework for CBD aligns with EU standards, allowing for the sale and use of compliant products.

 

Slovakia - Yes (with restrictions)

CBD products are legal in Slovakia under specific conditions, primarily concerning their THC content and intended use.

• Hemp Cultivation: Permitted for industrial purposes using EU-certified seeds, with THC content not exceeding 0.2%. However, cultivation for the purpose of producing CBD extracts is prohibited.
• CBD Flowers: The sale and possession of CBD-rich hemp flowers are prohibited, regardless of THC content.
• CBD Products: CBD oils and cosmetics are legal if they contain less than 0.2% THC and are derived from authorized hemp varieties. Ingestible CBD products, such as supplements and edibles, require authorization under the EU Novel Food Regulation.
• Medical Cannabis: Illegal. Slovakia does not have a medical cannabis program, and the use of cannabis-based medications is prohibited.
• Recreational Cannabis: Illegal. Possession and use are criminal offenses, with penalties including fines and imprisonment.
• Consumer Access: CBD products meeting legal requirements are available in stores and online. Consumers should ensure products comply with THC limits and are sourced from authorized hemp varieties.

Slovakia's regulatory framework for CBD aligns with EU standards, allowing for the sale and use of compliant products.

 

Slovenia - Yes

In Slovenia, the legal status of CBD products depends on product classification and national enforcement. The broader cannabis framework was significantly updated in August 2025, affecting the medical cannabis sector.

• Hemp Cultivation: Legal under EU-aligned rules. Approved industrial hemp varieties may be cultivated with up to 0.3% THC at the cultivation stage.
• CBD Flowers: Restricted. Flowers are generally treated as cannabis material and are not clearly permitted for retail sale, regardless of THC content.
• CBD Products: CBD cosmetics are available on the market. Ingestible CBD products (oils, supplements, edibles) remain subject to EU Novel Food considerations and national enforcement practices. No officially defined THC threshold guarantees legality for finished ingestible products.
• Medical Cannabis: Legal. A new medical and scientific cannabis framework entered into force on 20 August 2025, expanding access within a regulated system.
• Recreational Cannabis: Illegal. Non-medical use and possession remain prohibited.
• Consumer Access: Moderate. Non-ingestible CBD products are more accessible, while edible and supplement products require careful compliance review.

Slovenia offers a regulated but conservative CBD environment, where medical cannabis reforms do not automatically translate into broader CBD food or supplement legality.

 

Spain - Yes (with restrictions)

CBD is permitted in Spain primarily as a topical/cosmetic product. Ingestible CBD oils, supplements, and edibles are generally not authorized for sale as consumable products.

• Hemp Cultivation: Legal under license using approved industrial hemp varieties (EU cultivation threshold ≤ 0.3% THC for eligible varieties).
• CBD Flowers: Not clearly permitted for consumer sale. Flowers remain sensitive and are commonly treated as cannabis material.
• CBD Products: Topical/cosmetic CBD products are commonly sold. Products intended for ingestion (oils, tinctures, capsules, edibles) are generally not accepted as food or food supplements under Novel Food logic and Spanish enforcement. Labels typically avoid ingestion claims.
• Medical Cannabis: Limited and developing; access remains narrow and regulated.
• Recreational Cannabis: Illegal (with social club realities, but not a general legal retail framework).
• Consumer Access: High for cosmetics; low for ingestible CBD products.

Spain is one of the clearest “cosmetics-first” CBD markets. If you sell oils there, they must be positioned and labeled accordingly.

 

Sweden - Yes (with restrictions)

CBD is extremely restricted in Sweden. Swedish enforcement is effectively zero-tolerance for THC, meaning CBD products must be THC-free (0.0% with no detectable THC) to avoid being treated as narcotics.

• Hemp Cultivation: Legal under license using approved hemp varieties (EU cultivation threshold ≤ 0.3% THC for eligible varieties), but downstream product rules remain strict.
• CBD Flowers: Not realistically permitted for consumer sale. Flowers are treated as cannabis material and carry high enforcement risk.
• CBD Products: Only CBD products that are genuinely THC-free are viable. Even trace THC can trigger classification as a controlled substance. Products may also face additional scrutiny depending on intended use and claims.
• Medical Cannabis: Very limited and tightly controlled; access depends on approved medicines and strict prescribing practice.
• Recreational Cannabis: Illegal. Possession and use remain criminal offenses.
• Consumer Access: Low. Market access is primarily limited to THC-free products, with very strict compliance expectations.

Sweden is best approached as a THC-zero jurisdiction. If your COA shows any THC trace, it is high risk.

Other non-EU countries

 

United Kingdom - Yes

CBD products are legal in the UK, provided they adhere to specific regulations concerning THC content and product classification.

• Hemp Cultivation: Permitted under license for industrial purposes using EU-approved seeds. Cultivation for CBD extraction requires authorization.
• CBD Flowers: The sale and possession of CBD-rich hemp flowers are prohibited, regardless of THC content.
• CBD Products: CBD oils, cosmetics, and other products are legal if they contain less than 1 mg of THC per container and are derived from authorized hemp varieties. Ingestible CBD products, such as supplements and edibles, require authorization under the UK's Novel Food Regulation.
• Medical Cannabis: Legal under strict conditions. Access to cannabis-based medications requires a prescription and is limited to specific medical conditions.
• Recreational Cannabis: Illegal. Possession and use are criminal offenses, with penalties including fines and imprisonment.
• Consumer Access: CBD products meeting legal requirements are available in stores and online. Consumers should ensure products comply with THC limits and are sourced from authorized hemp varieties.

The UK's regulatory framework for CBD aligns with evolving standards, allowing for the sale and use of compliant products.

Iceland - Yes (with restrictions)

CBD products are legal in Iceland under strict conditions, primarily concerning their THC content and classification as medicinal products.

• Hemp Cultivation: Permitted for industrial purposes using EU-certified seeds, with THC content not exceeding 0.2%.
• CBD Flowers: The sale and possession of CBD-rich hemp flowers are prohibited, regardless of THC content.
• CBD Products: CBD oils and cosmetics are legal if they contain no detectable THC and are derived from authorized hemp varieties. Ingestible CBD products, such as supplements and edibles, require authorization under the EU Novel Food Regulation.
• Medical Cannabis: Legal under strict conditions. Access to cannabis-based medications requires a prescription and is limited to specific medical conditions.
• Recreational Cannabis: Illegal. Possession and use are criminal offenses, with penalties including fines and imprisonment.
• Consumer Access: CBD products meeting legal requirements are available in pharmacies and online. Consumers should ensure products comply with THC limits and are sourced from authorized hemp varieties.

Iceland's regulatory framework for CBD aligns with EU standards, allowing for the sale and use of compliant products.

Switzerland - Yes (with restrictions)

CBD is legal in Switzerland under a much higher THC limit than in the EU. Switzerland allows cannabis products containing up to 1.0% THC, but Swiss rules do not align with the EU Novel Food frameworks.

• Hemp Cultivation: Legal under Swiss rules, with THC limits up to 1.0% THC.
• CBD Flowers: Widely sold and regulated under Swiss law when compliant with the ≤ 1.0% THC rule.
• CBD Products: Oils, cosmetics, and other CBD products are widely available if they comply with Swiss requirements and marketing restrictions.
• Medical Cannabis: Legal and regulated.
• Recreational Cannabis: Not broadly legalized like Canada/Uruguay; Swiss policies are evolving via pilots and regulated programs.
• Consumer Access: High compared to most of Europe due to the 1.0% THC threshold.

Switzerland is often cited in “European CBD” discussions, but it should be treated as a separate regulatory system from the EU.

Norway - Yes (with restrictions)

CBD products are legal in Norway under strict conditions, primarily concerning their THC content and classification as medicinal products.

• Hemp Cultivation: Prohibited. Cultivation of cannabis, including hemp, is illegal in Norway.
• CBD Flowers: The sale and possession of CBD-rich hemp flowers are prohibited, regardless of THC content.
• CBD Products: CBD oils and cosmetics are legal if they contain no detectable THC and are derived from authorized hemp varieties. Ingestible CBD products, such as supplements and edibles, require authorization under the EU Novel Food Regulation.
• Medical Cannabis: Legal under strict conditions. Access to cannabis-based medications requires a prescription and is limited to specific medical conditions.
• Recreational Cannabis: Illegal. Possession and use are criminal offenses, with penalties including fines and imprisonment.
• Consumer Access: CBD products meeting legal requirements are available in pharmacies and online. Consumers should ensure products comply with THC limits and are sourced from authorized hemp varieties.

Norway's regulatory framework for CBD is among the strictest in Europe, allowing only THC-free products classified as medicines.

Other Balkan Countries

🇧🇦 Bosnia and Herzegovina – Legal Status: No

• Hemp Cultivation: Permitted for industrial purposes with THC content not exceeding 0.2%.
• CBD Products: Illegal. The production, sale, and possession of CBD products are prohibited.
• Medical Cannabis: Not regulated.
• Recreational Cannabis: Illegal.

🇲🇰 North Macedonia – Legal Status: Yes (with restrictions)

• Hemp Cultivation: Permitted for medical purposes.
• CBD Products: Legal for medical use. Oils containing up to 0.2% THC can be purchased without a prescription; higher THC products require a prescription.
• Medical Cannabis: Legal under strict conditions.
• Recreational Cannabis: Illegal.

🇷🇸 Serbia – Legal Status: Yes (with restrictions)

• Hemp Cultivation: Permitted for industrial purposes with THC content not exceeding 0.3%.
• CBD Products: Legal. CBD is unrestricted despite previous attempts to schedule it.
• Medical Cannabis: Illegal.
• Recreational Cannabis: Illegal.

🇲🇪 Montenegro – Legal Status: No

• Hemp Cultivation: Permitted for industrial purposes with THC content not exceeding 0.2%.
• CBD Products: Illegal. The sale and use of cannabis products, including CBD, are prohibited.
• Medical Cannabis: Illegal.
• Recreational Cannabis: Illegal.

🇦🇱 Albania – Legal Status: Yes (with restrictions)

• Hemp Cultivation: Permitted for industrial and medical purposes.
• CBD Products: Considered medical cannabis; production is allowed for export only.
• Medical Cannabis: Legal under strict conditions.
• Recreational Cannabis: Illegal.

🇽🇰 Kosovo – Legal Status: No

• Hemp Cultivation: Permitted for industrial purposes.
• CBD Products: Illegal. The legal framework is ambiguous, but CBD products are generally prohibited.
• Medical Cannabis: Illegal.
• Recreational Cannabis: Illegal.

🇲🇩 Moldova – Legal Status: Yes (with restrictions)

• Hemp Cultivation: Permitted for industrial purposes.
• CBD Products: Legal if derived from industrial hemp with THC content not exceeding 0.2%.
• Medical Cannabis: Illegal.
• Recreational Cannabis: Illegal.

Other countries

The legal status of CBD products in these microstates varies, with most maintaining strict regulations or outright prohibitions.

🇱🇮 Liechtenstein – Legal Status: No

• Hemp Cultivation: Prohibited.
• CBD Flowers: Prohibited.
• CBD Products: Illegal. The production, sale, and possession of any form of medicinal marijuana products, including CBD, are prohibited.
• Medical Cannabis: Illegal.
• Recreational Cannabis: Illegal.

🇦🇩 Andorra – Legal Status: No

• Hemp Cultivation: Prohibited.
• CBD Flowers: Prohibited.
• CBD Products: Illegal. CBD is considered a medicine of high complexity and can only be dispensed in hospital pharmacies.
• Medical Cannabis: Illegal.
• Recreational Cannabis: Illegal.

🇲🇨 Monaco – Legal Status: No

• Hemp Cultivation: Prohibited.
• CBD Flowers: Prohibited.
• CBD Products: Illegal. Both medical and recreational cannabis are illegal in Monaco.
• Medical Cannabis: Illegal.
• Recreational Cannabis: Illegal.

🇸🇲 San Marino – Legal Status: Yes (with prescription)

• Hemp Cultivation: Permitted under strict regulations.
• CBD Flowers: Prohibited.
• CBD Products: Legal for medical purposes. San Marino has entered the medical cannabis market with its first licensed producer.
• Medical Cannabis: Legal under strict conditions.
• Recreational Cannabis: Illegal.

🇻🇦 Vatican City – Legal Status: No

• Hemp Cultivation: Prohibited.
• CBD Flowers: Prohibited.
• CBD Products: Illegal. The production, sale, and possession of any form of medicinal marijuana products are prohibited.
• Medical Cannabis: Illegal.
• Recreational Cannabis: Illegal.

Conclusion

As CBD continues to grow in popularity, Europe has become one of the most dynamic and fragmented markets for hemp-derived products. While the European Union has made steps toward harmonizing CBD laws, especially through Novel Food and cosmetic regulations, each country still sets its own rules—resulting in a complex legal patchwork.

As of 2026, CBD is legal in most European countries, but the requirements vary greatly. Some countries—like Germany, France, and the Netherlands—have progressive frameworks with clear THC limits and defined cosmetic or food use. Others, like Sweden and the UK, only allow THC-free products. And in places such as Italy, Ireland, and Portugal, CBD is often treated as a medicine and only available with a prescription.

Additionally, several non-EU and Balkan nations remain restrictive or ambiguous, and many microstates such as Monaco, Andorra, and the Vatican still prohibit CBD outright.

It's also important to note that rules for hemp cultivation, CBD flower sales, and medical cannabis access differ significantly from one country to another—even within the EU. Some nations allow industrial hemp farming but ban CBD product sales. Others approve only topicals, while food supplements remain under regulatory review.

At Essentia Pura, we monitor these developments closely, but please remember:
👉 This article is for informational purposes only.
👉 CBD laws are evolving constantly, and this guide may become outdated.
👉 We do not guarantee the accuracy of this information at the time of reading.

Still, this resource should serve as a solid foundation for understanding the European CBD landscape in 2026. Whether you're a consumer, distributor, or manufacturer, thorough legal research is essential before entering any national market.

**Last updated in January 2026

About us

At Essentia Pura, we specialize in manufacturing high-quality white label CBD and private label CBD products, helping businesses launch their own unique CBD brands. With cutting-edge hemp extraction methods and a commitment to compliance and quality, we support companies in the nutraceutical, pharmaceutical, and cosmetic industries. Whether you’re looking for ready-to-market formulations or custom solutions, we’re here to help you succeed in the growing CBD market.

You ask. We Answer.